What to Expect in 2026?
Returning to Boston for its 4th year, the Viral Vector Process Development & Manufacturing Summit brings together the global community redefining scalable, safe, and cost-efficient viral vector production.
This year’s program features two days of cutting-edge discussions, technical case studies, and collaborative roundtables focused on driving down COGs, improving analytical precision, and enabling regulatory readiness. By addressing these core challenges head-on, you’ll uncover practical strategies to make vector manufacturing more cost-efficient, reproducible, and compliant with safety standards – ultimately accelerating time to marker, ensuring consistent product quality at scale and strengthening the commercial viability of advanced cell and gene therapy programs.
Attendees will walk away with practical solutions to streamline upstream and downstream workflows, harness automation and digital analytics for GMP scalability, and stay ahead of shifting global regulatory and pharmacopeial standards.
The Moments You Won’t Want to Miss
Driving Down the Cost of Goods
Learn from Ultragenyx, Sanofi, and Cabaletta Bio as they reveal practical strategies to reduce plasmid dependency, improve upstream yield, and simplify raw-material supply chains - unlocking scalable, low-cost viral vector manufacturing.
Strengthening Process Consistency & Regulatory Readiness
Hear directly from NCI, USP, and leading CMC experts on establishing robust QC and analytical frameworks to ensure batch-to-batch reproducibility, safety, and alignment with evolving global guidance.
Reconnect, Collaborate & Expand Your Network
Engage in over six hours of structured networking, including roundtable discussions and speed networking, designed to spark collaboration and build lasting partnerships across biopharma, CDMOs, and regulatory peers.
Explore The Full Event Guide
- 16+ expert speakers from the likes of Sanofi, Ultragenyx, NCI, USP, Apertura, and Rocket Pharma
- 2 days of cutting-edge content tackling the toughest challenges in reducing COGs, improving process consistency, and scaling up viral vector production
- 5 Interactive sessions and 2 hours of dedicated networking
- Dedicated sessions on upstream and downstream streamlining
- Global perspectives on regulatory harmonization and pharmacopeial alignment
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.